2 min read
Apples to Apples: Playing the Comparability Game in Biotherapeutics Development
Comparability studies are a significant issue for those working in biotherapeutics development, as undetected product changes are considered high risk.
Listen to the full episode on Veristat’s Advancing Revolutionary Therapies Podcast to get important insights and recommendations on how to successfully plan your clinical and CMC manufacturing development plans to reduce your regulatory risk along the way.
Learning Points
- The importance of comparability studies for biologics
- Key aspects of a comparability assessment
- How to determine analytical and stability parameters when measuring comparability
- Conditions for evaluating stability studies
Meet Veristat. Learn More.
Get the Latest News
Categories
- Regulatory Consulting (140)
- Regulatory Submissions (134)
- Clinical Trial Regulations (122)
- COVID-19 (46)
- Strategic Consulting (39)
- Clinical Trials (35)
- Life At Veristat (20)
- Oncology (18)
- Events (16)
- Success Stories (13)
- Clinical Operations/Monitoring (12)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Full-Service (9)
- Medical Writing (9)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Neurology/CNS (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Psychedelics (2)
- Rare Diseases (2)
- AI (1)
- Global Markets (1)
- Hematology (1)
- InStat (1)
- Medical Affairs (1)
3 min read
Meet Veristat at RAPS Convergence 2026
Aug 26, 2026 Veristat Events
Where Regulatory Strategy Meets What’s Next
RAPS Convergence US: September 15-17, 2026 – Charlotte, NC
Veristat is...